Unusual variants of malignant melanoma

被引:180
作者
Magro, CM
Crowson, AN
Mihm, MC
机构
[1] Ohio State Univ, Div Dermatopathol, Dept Pathol, Columbus, OH 43215 USA
[2] Univ Oklahoma, Dept Dermatol, Tulsa, OK USA
[3] Univ Oklahoma, Dept Pathol, Tulsa, OK USA
[4] Univ Oklahoma, Dept Surg, Tulsa, OK USA
[5] St Johns Hosp, Reg Med Labs, Tulsa, OK USA
[6] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Dermatol, Boston, MA USA
[7] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Pathol, Boston, MA USA
关键词
melanoma; variants; phenotype; immunohistochemistry; morphology;
D O I
10.1038/modpathol.3800516
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
A potential diagnostic pitfall in the histologic assessment of melanoma is the inability to recognize unusual melanoma variants. Of these, the more treacherous examples include the desmoplastic melanoma, the nevoid melanoma, the so-called 'minimal-deviation melanoma,' melanoma with prominent pigment synthesis or,animal-type melanoma,' and the malignant blue nevus. Also problematic are the unusual phenotypic profiles seen in vertical growth phase melanomas; these include those tumors whose morphological peculiarities mimic cancers of nonmelanocytic lineage and those melanomas that express aberrant antigenic profiles not commonly associated with a melanocytic histogenesis. Metaplastic change in melanoma, balloon cell melanoma, signet-ring cell melanoma, myxoid melanoma, small cell melanoma and rhabdoid melanoma all have the potential to mimic metastatic and primary neoplasms of different lineage derivations. Abnormal immunohistochemical expression of CID 34, cytokeratins, epithelia[ membrane antigen, and smooth muscle markers as well as the deficient expression of S100 protein and melanocyte lineage-specific markers such as GIR100 protein (ie HMB-45 antibody) and A103 (ie Melan-A) also present confusing diagnostic challenges. In this review, we will discuss in some detail certain of these novel clinicopathologic types of melanoma, as well as the abnormal phenotypic expressions seen in vertical growth phase melanoma.
引用
收藏
页码:S41 / S70
页数:30
相关论文
共 50 条
  • [41] COX-2 Silencing in Canine Malignant Melanoma Inhibits Malignant Behaviour
    Silveira, Tatiany L.
    Pang, Lisa Y.
    Di Domenico, Alexandra
    Veloso, Emerson S.
    Silva, Istefani L. D.
    Del Puerto, Helen L.
    Ferreria, Enio
    Argyle, David J.
    FRONTIERS IN VETERINARY SCIENCE, 2021, 8
  • [42] MALIGNANT MELANOMA IN THE PENGUIN: CHARACTERIZATION OF THE CLINICAL, HISTOLOGIC, AND IMMUNOHISTOCHEMICAL FEATURES OF MALIGNANT MELANOMA IN 10 INDIVIDUALS FROM THREE SPECIES OF PENGUIN
    Duncan, Ann E.
    Smedley, Rebecca
    Anthony, Simon
    Garner, Michael M.
    JOURNAL OF ZOO AND WILDLIFE MEDICINE, 2014, 45 (03) : 534 - 549
  • [43] Malignant melanoma of the nose
    A. Sil
    P. Chatrath
    N. Warwick-Brown
    Indian Journal of Otolaryngology and Head and Neck Surgery, 2004, 56 (1) : 59 - 62
  • [44] Treatment of malignant melanoma
    García, ED
    Santolaya, R
    Requena, T
    ANNALS OF PHARMACOTHERAPY, 1999, 33 (06) : 730 - 738
  • [45] Uveal malignant melanoma
    Katsuhiko Kato
    Annals of Nuclear Medicine, 2003, 17 (7) : 612 - 612
  • [46] Prevention of malignant melanoma
    Bauer, J.
    ONKOLOGE, 2012, 18 (03): : 224 - 229
  • [47] Prevention of malignant melanoma
    Bauer, J.
    ONKOLOGE, 2012, 18 (03): : 224 - 229
  • [48] Interferon and malignant melanoma
    Dreno, B
    REVUE DE MEDECINE INTERNE, 2002, 23 : 489S - 493S
  • [49] Immunotherapy of malignant melanoma
    Braathen, LR
    Hunger, RE
    Brand, CU
    ZENTRALBLATT FUR CHIRURGIE, 2000, 125 (10): : 806 - 809
  • [50] The genetics of malignant melanoma
    Lomas, Jesus
    Martin-Duque, Pilar
    Pons, Mar
    Quintanilla, Miguel
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 : 5071 - 5093